Citation: Ca. Lang et Df. Ransohoff, WHAT CAN WE CONCLUDE FROM THE RANDOMIZED CONTROLLED TRIALS OF FECAL OCCULT BLOOD-TEST SCREENING, European journal of gastroenterology & hepatology, 10(3), 1998, pp. 199-204
Citation: Mm. Collins et al., DETECTION OF EARLY PROSTATE-CANCER - SERENDIPITOUS OR SYSTEMATIC - REPLY, JAMA, the journal of the American Medical Association, 279(18), 1998, pp. 1441-1441
Citation: Ca. Lang et Df. Ransohoff, ON THE SENSITIVITY OF FECAL OCCULT BLOOD-TEST SCREENING FOR COLORECTAL-CANCER, Journal of the National Cancer Institute, 89(19), 1997, pp. 1392-1393
Citation: Mm. Collins et al., EARLY DETECTION OF PROSTATE-CANCER - SERENDIPITY STRIKES AGAIN, JAMA, the journal of the American Medical Association, 278(18), 1997, pp. 1516-1519
Citation: Mw. Russo et al., RISKS AND BENEFITS OF ASPIRIN THERAPY FOR PREVENTION OF COLORECTAL-CANCER (CRC) AND MYOCARDIAL-INFARCTION IN AVERAGE RISK MEN, Gut, 41, 1997, pp. 66-66
Citation: Jf. Helm et al., SCREENING FOR COLORECTAL-CANCER (CRC) BY FECAL OCCULT BLOOD TESTING (FOBT) IS COST-EFFECTIVE, BUT IS IT AFFORDABLE, Gastroenterology, 112(4), 1997, pp. 18-18
Citation: Jf. Helm et al., WHAT DO WE GAIN BY SCREENING FOR COLORECTAL-CANCER (CRC) WITH 6 TESTSFOR FECAL OCCULT BLOOD, AND AT WHAT COST, Gastroenterology, 112(4), 1997, pp. 576-576
Citation: M. Pignone et Df. Ransohoff, NEW CONCEPTS TO UNDERSTAND SENSITIVITY IN FECAL OCCULT BLOOD TESTING, Gastroenterology, 112(4), 1997, pp. 639-639
Citation: Df. Ransohoff et Rp. Harris, LESSONS FROM THE MAMMOGRAPHY SCREENING CONTROVERSY - CAN WE IMPROVE THE DEBATE, Annals of internal medicine, 127(11), 1997, pp. 1029-1034
Citation: Df. Ransohoff et Ca. Lang, SUGGESTED TECHNIQUE FOR FECAL OCCULT BLOOD TESTING AND INTERPRETATIONIN COLORECTAL-CANCER SCREENING, Annals of internal medicine, 126(10), 1997, pp. 808-810
Citation: Df. Ransohoff et Ca. Lang, SCREENING FOR COLORECTAL-CANCER WITH THE FECAL OCCULT BLOOD-TEST - A BACKGROUND PAPER, Annals of internal medicine, 126(10), 1997, pp. 811-822
Citation: Mw. Russo et al., WEIGHING THE BENEFITS AND RISKS OF LOW-DOSE ASPIRIN IN PRIMARY PREVENTION OF COLORECTAL-CANCER (CRC), Gastroenterology, 110(4), 1996, pp. 36-36
Citation: S. Stearns et al., INCREASING THE EFFICIENCY OF SIGMOIDOSCOPY SCREENING - WHAT ARE SOURCES OF COST, Gastroenterology, 110(4), 1996, pp. 598-598
Authors:
OTCHY DP
RANSOHOFF DF
WOLFF BG
WEAVER A
ILSTRUP D
CARLSON H
RADEMACHER D
Citation: Dp. Otchy et al., METACHRONOUS COLON-CANCER IN PERSONS WHO HAVE HAD A LARGE ADENOMATOUSPOLYP, The American journal of gastroenterology, 91(3), 1996, pp. 448-454
Citation: Df. Ransohoff et Ck. Mcsherry, WHY ARE CHOLECYSTECTOMY RATES INCREASING, JAMA, the journal of the American Medical Association, 273(20), 1995, pp. 1621-1622
Citation: Ca. Lang et Df. Ransohoff, SCREENING FOR COLORECTAL-CANCER - WHICH TEST IS BEST - REPLY, JAMA, the journal of the American Medical Association, 272(14), 1994, pp. 1100-1100
Citation: Ca. Lang et Df. Ransohoff, FECAL OCCULT BLOOD SCREENING FOR COLORECTAL-CANCER - IS MORTALITY REDUCED BY CHANCE SELECTION FOR SCREENING COLONOSCOPY, JAMA, the journal of the American Medical Association, 271(13), 1994, pp. 1011-1013
Citation: Ca. Lang et Df. Ransohoff, COLORECTAL-CANCER SCREENING - COST-EFFECTIVENESS OF THE FECAL OCCULT BLOOD-TEST WITH AND WITHOUT REHYDRATION, Gastroenterology, 106(4), 1994, pp. 10000015-10000015
Citation: Sk. Mahajan et Df. Ransohoff, COMPLETENESS OF COLONOSCOPY VS BARIUM ENEMA IN EXAMINATION OF THE COLON, Gastroenterology, 106(4), 1994, pp. 10000016-10000016